Andrew R. Blight
2009
In 2009, Andrew R. Blight earned a total compensation of $1.3M as Chief Scientific Officer at Acorda Therapeutics, a 17% increase compared to previous year.
Compensation breakdown
| Bonus | $149,279 |
|---|---|
| Option Awards | $526,920 |
| Salary | $317,500 |
| Stock Awards | $329,440 |
| Other | $7,350 |
| Total | $1,330,489 |
Blight received $526.9K in option awards, accounting for 40% of the total pay in 2009.
Blight also received $149.3K in bonus, $317.5K in salary, $329.4K in stock awards and $7.4K in other compensation.
Rankings
In 2009, Andrew R. Blight's compensation ranked 3,542nd out of 9,885 executives tracked by ExecPay. In other words, Blight earned more than 64.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,542 out of 9,885 | 64th |
Division Manufacturing | 1,235 out of 3,690 | 67th |
Major group Chemicals And Allied Products | 241 out of 866 | 72nd |
Industry group Drugs | 140 out of 638 | 78th |
Industry Biological Products, Except Diagnostic Substances | 22 out of 133 | 84th |
Source: SEC filing on April 26, 2012.
Blight's colleagues
We found four more compensation records of executives who worked with Andrew R. Blight at Acorda Therapeutics in 2009.